Anticoagulation Prophylaxis in Pregnancy
Introduction to Heparin Prophylaxis
- The American College of Chest Physicians strongly recommends low-molecular-weight heparin (LMWH) over unfractionated heparin (UFH) for both prevention and treatment of venous thromboembolism (VTE) in pregnant women (Grade 1B) 1
- Heparin is highly suitable and recommended as the anticoagulant of choice for prophylaxis in pregnancy, as it does not cross the placental barrier and poses no teratogenic risk to the fetus 1, 2
Clinical Indications for Prophylaxis
- For pregnant women with prior VTE, prophylactic or intermediate-dose LMWH is recommended during pregnancy, followed by 6 weeks of postpartum anticoagulation (Grade 2B) 3
- The American College of Chest Physicians recommends antithrombotic prophylaxis for women with antiphospholipid syndrome (APS), with combined low-dose aspirin (75-100 mg/day) and prophylactic-dose LMWH (Grade 1B) 1, 4
- Prophylactic heparin should be considered for pregnant women requiring prolonged bed rest, particularly in cyanotic heart disease patients at risk of paradoxical embolism 5
Dosing and Monitoring Considerations
- Anti-Xa levels should be measured 4-6 hours after morning dose for LMWH dosing adjustment 2
- Target anti-Xa level of 0.7-1.2 units/mL for therapeutic LMWH therapy 2
Peripartum Management
- LMWH should be discontinued at least 24 hours before planned induction of labor, cesarean section, or neuraxial anesthesia (Grade 1B) to reduce hemorrhagic complications 3
Postpartum Anticoagulation
- All pregnant women with a history of VTE require postpartum prophylaxis for 6 weeks with either LMWH at prophylactic or intermediate doses, or vitamin K antagonists with INR target of 2.0-3.0 (Grade 2B) 3
- For women receiving anticoagulation for acute VTE treatment, continue anticoagulants for at least 6 weeks postpartum for a minimum total duration of 3 months (Grade 2C) 1